ASO GROUP Ltd Purchases Shares of 1,748 Elevance Health, Inc. $ELV

ASO GROUP Ltd purchased a new stake in shares of Elevance Health, Inc. (NYSE:ELV) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 1,748 shares of the company’s stock, valued at approximately $613,000.

Several other institutional investors have also added to or reduced their stakes in ELV. Rossby Financial LCC boosted its position in Elevance Health by 110.0% during the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company’s stock valued at $28,000 after buying an additional 44 shares during the period. J.Safra Asset Management Corp purchased a new stake in Elevance Health during the 4th quarter valued at $32,000. ORG Partners LLC boosted its position in Elevance Health by 120.4% during the 4th quarter. ORG Partners LLC now owns 108 shares of the company’s stock valued at $38,000 after buying an additional 59 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new stake in Elevance Health during the 4th quarter valued at $38,000. Finally, Dorato Capital Management purchased a new stake in Elevance Health during the 4th quarter valued at $41,000. Hedge funds and other institutional investors own 89.24% of the company’s stock.

Elevance Health Stock Down 1.2%

Shares of NYSE ELV opened at $399.64 on Friday. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.70. Elevance Health, Inc. has a 12 month low of $273.71 and a 12 month high of $426.98. The firm has a market capitalization of $86.79 billion, a PE ratio of 17.00, a price-to-earnings-growth ratio of 2.29 and a beta of 0.67. The firm has a fifty day simple moving average of $364.53 and a two-hundred day simple moving average of $344.44.

Elevance Health (NYSE:ELV) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $12.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.74 by $1.84. The company had revenue of $49.49 billion during the quarter, compared to analyst estimates of $48.21 billion. Elevance Health had a net margin of 2.62% and a return on equity of 15.58%. Elevance Health’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period last year, the business earned $11.97 EPS. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Equities analysts expect that Elevance Health, Inc. will post 26.93 earnings per share for the current year.

Elevance Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be paid a $1.72 dividend. This represents a $6.88 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Wednesday, June 10th. Elevance Health’s dividend payout ratio (DPR) is presently 29.26%.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Robert W. Baird increased their price target on shares of Elevance Health from $317.00 to $331.00 and gave the company a “neutral” rating in a research report on Thursday, April 23rd. UBS Group increased their price target on shares of Elevance Health from $400.00 to $460.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. Citigroup upgraded shares of Elevance Health to a “buy” rating in a report on Wednesday, April 29th. The Goldman Sachs Group upped their price objective on shares of Elevance Health from $350.00 to $370.00 and gave the stock a “neutral” rating in a report on Friday, April 24th. Finally, Jefferies Financial Group decreased their price objective on shares of Elevance Health from $395.00 to $391.00 and set a “buy” rating for the company in a report on Monday, April 20th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $416.11.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.